Panel Says Yaz Label Should Be Re-Written

In a 21 to 5 vote, the U.S. Food and Drug Administration said that the labels on certain oral contraceptive drugs should be rewritten to reflect risks accurately. The pills in question contain the hormone drospirenone. The brand names for these products include Yaz, Yasmin, Beyaz and Sayfral. Some studies suggest that the risk is higher for venous thromboembolism (VTE) in birth control pills with drospirenone than those with another hormone called levonorgestrel, a progestin. VTE occurs when blood clots …

Continue →

FDA Concerned About Yaz

The FDA is remaining concerned about a type of birth control pill that could raise the risk of blood clots more than other pills on the market. The pills known as Yaz or Yasmin, marketed by Bayer AG, contain drospirenone. Drospirenone is a type of female sex hormone called a progestin. Although all birth control pills raise the risk of blood clots, some studies have reported that the risk of blood clots for women who use birth-control pills containing drospirenone …

Continue →

FDA Reviews Birth Control Blood Clot Risk

The Food and Drug Administration is reviewing the risk of birth control pills Yaz and Yasmin after multiple studies found that women taking the pills are more likely to develop venous thromboembolism. Venous thromboembolism refers to blood clots that develop in the deep veins of the legs. According to studies published in BMJ, women aged 15-44 who take pills containing drospirenone—like Bayer-manufactured Yaz and Yasmin—were two to three times more likely to have blood clots than women who take older …

Continue →

Oral Contraceptives May Decrease Bone Density in Younger Women, Study Suggests

Younger women taking oral contraceptives may be at greater risk of developing decreased bone density, a new study says.

Continue →

Yaz Injury Lawsuits Could Top 25,000 Cases

More than 25,000 lawsuits could be filed across the United States for serious and deadly injuries allegedly caused by the contraceptive Yaz and consolidated in an Illinois federal court. U.S. District Chief Judge David Herndon has been assigned the task of presiding over thousands of lawsuits against Bayer Corp. The cases accuse the birth-control pills Yaz, Yasmin, and Ocella of causing women to suffer increased risks of heart attack, stroke, blood clots, deep vein thrombosis, pulmonary embolism, gallbladder disease, and …

Continue →

Yaz Lawsuits Seek Compensation for Life-Threatening Injuries

More than 150 personal-injury lawsuits have now been filed on behalf of women across the United States who used the popular birth control pills Yaz, Yasmin, and Ocella and suffered a potentially deadly heart attack, stroke, blood clot, pulmonary embolism, gallbladder disease, or other injury.

Continue →

Yaz Judge Likely to Limit Questioning About Plaintiffs’ Sex Lives

The judge presiding over hundreds of Yaz birth control pill injury lawsuits has indicated she will not allow attorneys for the drug’s maker to delve too deeply into the sexual history of women bringing the lawsuits.

Continue →

Woman Sues Bayer Claiming Yaz Caused Her Blood Clot

An Ohio woman has filed a lawsuit against the maker of the birth-control pill Yaz, claiming the company failed to adequately warn her and other users about the serious risks of life-threatening blood clots and other injuries.

Continue →

Contraceptive Yaz Linked to Deadly Gallbladder Disease, Blood Clots

The prescription birth-control drug Yaz and the related drugs Yasmin and Ocella have been shown to cause potentially deadly gallbladder disease, blood clots, and other serious health complications in women taking the pills to avoid becoming pregnant or treat a variety of other medical conditions.

Continue →

N.J. Yaz-Yasmin Injury Lawsuits May be Centralized as Mass Tort

A New Jersey state court judge has asked that all state lawsuits filed over injuries allegedly caused by taking the birth-control pills Yaz, Yasmin, and Ocella be treated as a mass tort and assigned to one judge.

Continue →